NEWS
Gene Predictis® closes its first financing round
Gene Predictis®, a Swiss precision medicine company, announces…
Pill Protect®: The first clinically validated test for identifying women at risk of developing deep vein thrombosis (DVT) under contraceptive pills
Gene Predictis®, a Swiss precision medicine company, has completed…
Gene Predictis wins the Alpine High-tech Venture Forum Award 2015
Gene Predictis is a winner of the 2015 Alpine High-tech Venture…
Gene Predictis SA received the CTI Start-Up Label certification
Gene Preditis has been awarded the CTI Start-Up Label on September…
Gene Predictis in press
We are happy to share with you our recent press release:
…
Gene Predictis SA inaugurates new laboratories at Science Park EPFL in Lausanne
In August 2012, Gene Predictis SA moved its headquarters and…